Home - Translational Lung Cancer Research

Join us at the IASLC 2026 World Conference on Lung Cancer

The IASLC 2026 World Conference on Lung Cancer (WCLC) is going to be held in Seoul, Republic of Korea from September 12th to 15th, 2026: https://wclc.iaslc.org/

This year Translational Lung Cancer Research (TLCR), along with its sister journals and books published by AME Publishing Company, will be featured at this exciting academic event. We look forward to connecting with our authors, editorial board members, and readers on this exciting occasion. You are warmly invited to visit us at Booth 708. For your convenience, the official exhibition hall floor plan is available for reference.

We look forward to meeting you onsite!

New Impact Factor for Translational Lung Cancer Research: 3.4

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor for the 2025 citation year: 3.4.

Translational Lung Cancer Research 2025 CiteScore Released: 4.6

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has achieved its 2025 CiteScore: 4.6, ranking 183 out of 428 journals in the Oncology category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

TLCR Annual Report 2025

Welcome to the 2025 annual report for Translational Lung Cancer Research. In 2025, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2025, and we look forward to continuing our work with you in the new year.

AME and Wolters Kluwer aim to expand access to global medical research through new collaboration

The agreement broadens the reach of nearly 50 Open Access titles, contributing globally to over 5,000 articles

October 2, 2025 — Wolters Kluwer Health announced a new collaboration with AME Publishing Company, an Open Access publisher specializing in medical journals and books, headquartered in Hong Kong, China.

Interviews with Outstanding Authors (2026)

In 2026, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2026)

In 2026, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

‹ ›

Vol 15, No 8 (August, 2026)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Original Article

Prognostic impact of CEACAM5 in nonsquamous non-small cell lung cancer: a critical reappraisal driven by cut-off optimization

Qian-Qian Xue, Yan Jin, Xu-Xia Shen, Qiang Zheng, Yao Fu, Qing-Xin Xia, Yuan Li

Translational Lung Cancer Research

2026;

(8)

:218

(31 August 2026)

PDF Full Text (63) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Surgical and pathologic efficacy of neoadjuvant immunochemotherapy in EGFR-mutant non-small cell lung cancer

Sangtian Liu, Qilin Deng, Shicui Quan, Wenhua Liang, Jianxing He

Translational Lung Cancer Research

2026;

(8)

:219

(31 August 2026)

PDF Full Text (69) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Comparison of diagnostic yield between electromagnetic navigation bronchoscopy-guided forceps biopsy and target-fixing technique-assisted RP-EBUS-guided transbronchial cryobiopsy with a guide sheath for peripheral lung lesions

Taehun Kim, Jae Woon Song, Jung Hee Hong, Seong Hwan Youn, Hyun Jung Kim, Jae Seok Park, Sun Hyo Park

Translational Lung Cancer Research

2026;

(8)

:220

(31 August 2026)

PDF Full Text (58) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic impact of smoking in non-small cell lung cancer: histology-specific findings from a retrospective cohort study

Hyo Kyen Park, Geun Dong Lee, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Jae Kwang Yun

Translational Lung Cancer Research

2026;

(8)

:221

(31 August 2026)

PDF Full Text (46) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Adjuvant chemotherapy and survival after resection for pulmonary large-cell neuroendocrine carcinoma: a dual-center time-dependent analysis

Linchuan Liang, Lei Liu, Yicheng Liang, Minjun Du, Mei Liang, Zixu Liu, Boxuan Zhou, Jianwei Shi, Yeye Chen, Shanqing Li, Yushun Gao

Translational Lung Cancer Research

2026;

(8)

:222

(31 August 2026)

PDF Full Text (49) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Identification of candidate variants in plasma associated with early versus late disease progression under anti-PD-1 therapy in metastatic NSCLC

Aitor Rodriguez-Casanova, Patricia Mondelo-Macía, Luis Leon-Mateos, Jorge García-González, Nicolás Costa-Fraga, Jaime Dubbelman, María Ángeles Gómez-García, Irene Lorenzo-Gómez, Alicia Abalo, Laura Muinelo-Romay, Rafael López-López, Angel Díaz-Lagares

Translational Lung Cancer Research

2026;

(8)

:223

(31 August 2026)

PDF Full Text (79) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Development and validation of an interpretable medical deep foundation model for predicting occult lymph node metastasis in early-stage small cell lung cancer: a multicenter retrospective diagnostic study

Xu Jiang, Qin Peng, Jing Zhang, Alex Zwanenburg, Xin Peng, Chao Luo, Jialiang Ren, Lin Yang, Yajia Gu, Steffen Löck, Kunfeng Liu, Meng Li, Jianwei Wang

Translational Lung Cancer Research

2026;

(8)

:224

(31 August 2026)

PDF Full Text (43) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Pulmonary metastasectomy and response-adapted preoperative surveillance in resectable metastatic osteosarcoma: a single-center retrospective cohort study with long-term follow-up

Zhusheng Zhang, Tao Liang, Qi Liu, Xiaoqing Yang, Xiaoyan Chen, Ruixuan Liu, Junxiang Wen, Zhuochao Liu, Yucheng Fu, Yichen Xu, Shuxian Li, Renjie Lu, Yuhui Shen, Qiyuan Bao, Weibin Zhang

Translational Lung Cancer Research

2026;

(8)

:225

(31 August 2026)

PDF Full Text (43) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A predictive model for fusion gene positivity in treatment-naive advanced non-small cell lung cancer

Yike Wang, Yingbo Xie, Xuan Yao, Kelan Ke, Pei Ma, Fengnan Wang, Qin Liu, Xiaohong Xie, Ming Liu, Xinqing Lin, Chengzhi Zhou, Zhanhong Xie

Translational Lung Cancer Research

2026;

(8)

:226

(31 August 2026)

PDF Full Text (45) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association of FDG PET/CT and immune profiling with pathologic complete response after neoadjuvant immunotherapy in stage II–III non-small cell lung cancer

Eun Seong Lee, Saem Mul Park, Seunghun Lee, Sehui Kim, Juwhan Choi, Jun Hee Lee, Jae Seon Eo, Hyun Koo Kim, Hwan Seok Yong, Chun-Jen J. Chen, Heidi Robinson, P. Rod Dunbar, Sung Yong Lee

Translational Lung Cancer Research

2026;

(8)

:227

(31 August 2026)

PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Osimertinib vs. erlotinib combined with an angiogenesis inhibitor in EGFR-mutated non-small cell lung cancer with malignant pleural effusion: a retrospective cohort study

Tae Hata, Tadaaki Yamada, Koji Mikami, Toshihide Yokoyama, Tomohiro Oba, Yasuhiro Goto, Naoki Furuya, Shun Futamura, Hirokazu Taniguchi, Tamio Okimoto, Soichi Hirai, Sayaka Uda, Asuka Okada, Rie Watanabe, Naoko Ishizaki, Hayato Kawachi, Takashi Kijima, Koichi Takayama

Translational Lung Cancer Research

2026;

(8)

:228

(31 August 2026)

PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Predictive modeling of peripheral blood EGFR positivity in patients with advanced primary non-small cell lung cancer

Ying-Bo Xie, Yi-Ke Wang, Xuan Yao, Kelan Ke, Pei Ma, Feng-Nan Wang, Qin Liu, Xiao-Hong Xie, Ming Liu, Xin-Qing Lin, Cheng-Zhi Zhou, Zhan-Hong Xie

Translational Lung Cancer Research

2026;

(8)

:229

(31 August 2026)

PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association between oxidative stress index and lung cancer risk in idiopathic pulmonary fibrosis: an exploratory retrospective analysis

Kiyofumi Shimoji, Tetsu Hirakawa, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Hironobu Hamada, Hiroshi Iwamoto

Translational Lung Cancer Research

2026;

(8)

:230

(31 August 2026)

PDF Full Text (52) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Clinical, radiological, and histopathological features of checkpoint inhibitor-related pneumonitis: a retrospective cross-sectional analysis of 44 patients who underwent lung biopsy

Junyi Mo, Haiyi Deng, Yilin Yang, You Wei, Kangjing Ma, Jie Xiao, Juhong Jiang, Xinfei He, Meizhen Que, Chengzhi Zhou, Xinqing Lin

Translational Lung Cancer Research

2026;

(8)

:231

(31 August 2026)

PDF Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Highest mediastinal lymph node metastasis was not an independent prognostic factor in pathological stage N2 non-small cell lung cancer

Mu-Zi Yang, Jing-Sheng Cai, Zeng-Hao Chang, Xue Hou, Hao-Xian Yang

Translational Lung Cancer Research

2026;

(8)

:232

(31 August 2026)

PDF Full Text (34) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association between antibiotic exposure and outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: a single-center retrospective cohort study

Ying-Long Peng, Qian-Lin Huang, Hong-Yi Zhu, Zhi-Hong Chen, Yu Deng, Chang Lu, Chong-Rui Xu, Fa-Man Xiao, Qing Zhou

Translational Lung Cancer Research

2026;

(8)

:233

(31 August 2026)

PDF Full Text (41) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Tool-in-lesion confirmation and diagnostic yield of digital tomosynthesis-integrated robotic bronchoscopic biopsy of lung nodules

Joyce W. Y. Chan, Aliss T. C. Chang, Clarence H. W. Chan, Rainbow W. H. Lau, Calvin S. H. Ng

Translational Lung Cancer Research

2026;

(8)

:234

(31 August 2026)

PDF Full Text (33) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Perioperative safety and risk stratification of simultaneous resection for multiple pulmonary nodules via video-assisted thoracoscopic surgery: a retrospective cohort study

Jiantong Sun, Zhenyu Yang, Yin Ku, Jie Cao, Jixuan Zheng, Shiyou Wei, Lunxu Liu

Translational Lung Cancer Research

2026;

(8)

:235

(31 August 2026)

PDF Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Increasing incidence and improved survival of leptomeningeal metastasis in advanced lung cancer: a 10-year real-world cohort study

Jing Sun, Qian Zhang, Yehao Yang, Haicheng Wu, Wanchen Zhai, Yuwei Li, Linjing Zhou, Mengqi Bao, Yi Chen, Xiheng Yu, Yun Fan

Translational Lung Cancer Research

2026;

(8)

:236

(31 August 2026)

PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Is there a room for radical salvage resection in initially-unresectable non-small cell lung cancer patients after EGFR-TKI based therapy?

Feng Su, Hanzhang Chen, Guilin Peng, Jianxing He, Jingpei Li

Translational Lung Cancer Research

2026;

(8)

:237

(31 August 2026)

PDF Full Text (47) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Modality-specific survival outcomes of biomarker-matched therapy in unresected non-small cell lung cancer: a clinicogenomic cohort study

Jiantong Sun, Zhenyu Yang, Yin Ku, Mao Liu, Dongsheng Wu, Shiyou Wei, Lunxu Liu

Translational Lung Cancer Research

2026;

(8)

:238

(31 August 2026)

PDF Full Text (34) Reporting Checklist Peer Review File COI Form Open Access

Significant improvement in overall survival with postoperative traditional Chinese medicine in stage I lung adenocarcinoma: a real-world retrospective cohort study

Boyue Pang, Jianing Chen, Xiang Lv, Mengfan Wang, Li Wang, Chunxia Su, Sufang Zhang

Translational Lung Cancer Research

2026;

(8)

:239

(31 August 2026)

PDF Full Text (48) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Extended sleeve lobectomy after neoadjuvant chemo-immunotherapy: postoperative outcomes differ by surgical side

Jialiang Wen, Yuzhou Wang, Tao Wang, Tao Chen, Yichen Dong, Jingyu Chen, Long Xu, Jiajun Deng, Yunlang She, Junqi Wu, Lei Jiang, Diego Gonzalez-Rivas, Xuefei Hu, Chang Chen, Chenlu Yang

Translational Lung Cancer Research

2026;

(8)

:240

(31 August 2026)

PDF Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Optimizing neoadjuvant chemoimmunotherapy cycles based on radiologic response improves efficacy and survival in non-small cell lung cancer

Jingyu Chen, Yichen Dong, Juemin Yu, Jialiang Wen, Haojie Si, Huikang Xie, Xinjian Li, Minglei Yang, Junqiang Fan, Yunlang She, Wei Li, Xiwen Sun, Junqi Wu, Long Xu, Chang Chen, Deping Zhao

Translational Lung Cancer Research

2026;

(8)

:241

(31 August 2026)

PDF Full Text (48) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Combined association of genetic predisposition and healthy lifestyle with lung cancer risk: a population-based cohort study

Zheng Li, Wenhai Fu, Yu Jiang, Yi Feng, Xusen Zou, Yulin Zhao, Peiling Chen, Runchen Wang, Caichen Li, Jianxing He, Wenhua Liang

Translational Lung Cancer Research

2026;

(8)

:242

(31 August 2026)

PDF Full Text (29) Reporting Checklist Peer Review File COI Form Open Access

Prognostic value of SUV_peak and prognostic nutritional index in patients with pleural mesothelioma treated with platinum-based chemotherapy

Yoshiki Kato, Kosuke Hashimoto, Hisao Imai, Kyoichi Kaira, Reina Ishii, Naohito Hashimoto, Ou Yamaguchi, Atsuto Mouri, Hiroshi Kagamu, Ichiei Kuji

Translational Lung Cancer Research

2026;

(8)

:243

(31 August 2026)

PDF Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Urinary miR-574-5p as a candidate biomarker for early-stage lung adenocarcinoma: an exploratory case-control study

Ryota Nagashima, Masato Aragaki, Kanako C. Hatanaka, Yoshiki Shinomiya, Masaru Ushijima, Aki Fujiwara-Kuroda, Kazuto Ohtaka, Haruhiko Shiiya, Ryohei Chiba, Shinya Otsuka, Takumi Nakaya, Ritsu Omine, Tomoaki Kuji, Yutaka Hatanaka, Tatsuya Kato

Translational Lung Cancer Research

2026;

(8)

:244

(31 August 2026)

PDF Full Text (43) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Chest CT-detected pulmonary nodules across the COVID-19 pandemic in Guangzhou, China: a regression discontinuity-in-time study, 2013–2023

Wenjun Ye, Wenhai Fu, Yi Feng, Weizheng Zhang, Deliang Xiong, Hui Zhou, Bo Cheng, Caichen Li, Qi Cai, Xiwen Liu, Peiling Chen, Jianxing He, Wenhua Liang

Translational Lung Cancer Research

2026;

(8)

:245

(31 August 2026)

PDF Full Text (65) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Bronchoalveolar lavage fluid EGFR genotyping during bronchoscopic biopsy: concordance with tissue and additional molecular diagnostic yield in lung cancer

Duk Ki Kim, Jae Young Hur, Hee Joung Kim, In Ae Kim, Jeong Eun Lee, Chaeuk Chung, Da Hyun Kang, So-Yun Kim, Green Hong, Dongil Park, Kye Young Lee

Translational Lung Cancer Research

2026;

(8)

:246

(31 August 2026)

PDF Full Text (51) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

PSMA6 drives non-small cell lung cancer progression by stabilizing NEDD8 and activating NF-κB signaling

Shiyang Deng, Zixuan Li, Nan Liu, Yue Wang, Jialu Sun, Bin Guan, Jiang Du

Translational Lung Cancer Research

2026;

(8)

:247

(31 August 2026)

PDF Full Text (42) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Lepidic pattern as a favorable prognostic factor in pathologically high-risk stage I invasive lung adenocarcinoma

Zhaokang Huang, Jie Cao, Nan Chen, Zhiyu Peng, Zetao Liu, Xizhou Liao, Xiaorong Zong, Peidi Li, Chenglin Guo, Lunxu Liu, Jiandong Mei

Translational Lung Cancer Research

2026;

(8)

:248

(31 August 2026)

PDF Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

First-line pembrolizumab plus chemotherapy versus bevacizumab plus chemotherapy in response and survival outcomes in PD-L1-negative advanced non-squamous NSCLC: a retrospective comparative cohort study

Kuofang Huang, Shifei Pan, Huishu Dong, Haijiao Lu, Bo Yan, Jialin Qian, Tianqing Chu

Translational Lung Cancer Research

2026;

(8)

:249

(31 August 2026)

PDF Full Text (48) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Marginal benefit of segmentectomy over lobectomy in minimally invasive surgery for stage IA lung cancer

Yang Chen, Yiyang Wang, Chenlei Zhang, Sara Cattadori, Alessio Campisi, Sara Ricciardi, Shaoyuan Zhang, Wanpu Yan, Bofei Li, Rongji Mu, Hongxu Liu, Lijie Tan, Keneng Chen, Luigi Ventura, Maurizio Infante, Giuseppe Cardillo, Wentao Fang

Translational Lung Cancer Research

2026;

(8)

:250

(31 August 2026)

PDF Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Heterogeneous efficacy and predictors of response to immunotherapy in driver-mutant advanced NSCLC: a focus on EGFR and KRAS subtypes

Yan Zhu, Shuxue Wang, Chan Wang, Dantong Sun, Danhe Wang, Feiyan Ma, Shikai Wu

Translational Lung Cancer Research

2026;

(8)

:251

(31 August 2026)

PDF Full Text (52) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Adjuvant therapy after pathological complete response in patients with non-small cell lung cancer: a multicenter retrospective cohort study

Yuechen Cui, Xuguang Zhang, Miao Wang, Guanhua Liu, Chunquan Liu, Leina Sun, Zhanshuo Zhang, Shuo Wang, Jiping Xie, Zhenfa Zhang, Changli Wang, Bin Zhang, Mu Hu, Kang Zheng, Hongyan Wang, Hefei Li, Dongsheng Yue

Translational Lung Cancer Research

2026;

(8)

:252

(31 August 2026)

PDF Full Text (46) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Brief Report

Neo-DIANA: descriptive results of a prematurely terminated phase II trial of neoadjuvant atezolizumab, chemotherapy and bevacizumab in resectable EGFR-mutated NSCLC

Ana Collazo-Lorduy, Virginia Calvo, Ernest Nadal, Mariano Provencio; Spanish Lung Cancer Group (Fundación GECP)

Translational Lung Cancer Research

2026;

(8)

:253

(31 August 2026)

PDF Full Text (80) Peer Review File COI Form Open Access

Case Series

Using an artificial intelligence tool to improve the recognition of pseudoprogression in pleural mesothelioma patients treated with immunotherapy: a case series

Illaa Smesseim, Kalina Chupetlovska, Valerio Pugliese, Jacobus A. Burgers, Kevin B. W. Groot Lipman

Translational Lung Cancer Research

2026;

(8)

:254

(31 August 2026)

PDF Full Text (32) Reporting Checklist Peer Review File COI Form Open Access

Study Protocol

Emotional distress and clinical response to neoadjuvant chemoimmunotherapy in resectable non-small-cell lung cancer: a protocol for the prospective observational NeoFUSE-Lung cohort study

Yuanpu Wei, Hancheng Yin, Deliang Hou, Hao Chen, Guobing Xu, Bin Zheng, Chun Chen, Zhang Yang

Translational Lung Cancer Research

2026;

(8)

:255

(31 August 2026)

PDF Full Text (38) Reporting Checklist Peer Review File COI Form Open Access

Review Article

The effectiveness of concurrent training in lung cancer survivors: a systematic review

Leonor Anjos, Mário Cardoso Marques, Dulce Esteves, Henrique Pereira Neiva, Ricardo Madeira, Adriana Maia, Diogo Luís Marques

Translational Lung Cancer Research

2026;

(8)

:256

(31 August 2026)

PDF Full Text (36) Reporting Checklist Peer Review File COI Form Open Access

Next-generation oncolytic virotherapy for lung cancer: bridging innovative vector engineering with clinical immunotherapy

Jiliu Liu, Ruitong Zeng, Guoping Li, Junyi Wang, Anying Xiong, Xiang He

Translational Lung Cancer Research

2026;

(8)

:257

(31 August 2026)

PDF Full Text (53) Peer Review File COI Form Open Access

Clinical value of blood circulating tumor RNA (ctRNA) in liquid biopsy of lung cancer: a narrative review

Lei Zhu, Longjun Xian, Lu Zhou, Min Yi, Jili Li, Yi Liu, Shuxiao Ma, Lunxu Liu

Translational Lung Cancer Research

2026;

(8)

:258

(31 August 2026)

PDF Full Text (31) Reporting Checklist Peer Review File COI Form Open Access

The neuronal network of small cell lung cancer: a narrative review of the role of the nervous system in the pathogenesis and progression

Mateusz Gap, Filip Gajewski, Weronika Pająk, Joanna Pec, Jakub Kleinrok, Grzegorz Kurec, Paweł Krawczyk

Translational Lung Cancer Research

2026;

(8)

:259

(31 August 2026)

PDF Full Text (49) Reporting Checklist Peer Review File COI Form Open Access

Invasive mucinous adenocarcinoma of the lung: integrating molecular landscape, imaging phenotypes, and translational therapeutic strategies

Zihan Wang, Jiashuo Wang, Shiqi Liu, Shi Zong, Xiwen Wang

Translational Lung Cancer Research

2026;

(8)

:260

(31 August 2026)

PDF Full Text (45) Peer Review File COI Form Open Access

NRG1 fusions in non-small cell lung cancer: biology, diagnostics, and emerging HER2/HER3 therapies—a narrative review

Andrea Marini, Irene Stasi, Antonio Pellino, Enrico Sammarco, Azzurra Farnesi, Cecilia Barbara, Ermelinda De Maio, Samanta Cupini, Gianna Musettini, Giulia Acconci, Linda Bartalini, Luna Chiara Masini, Giulia Soria, Elena Sartori, Ylenia Nodari, Carmelo Spinella, Luigi Coltelli, Adele Servadio, Andrea Giusti, Giacomo Allegrini

Translational Lung Cancer Research

2026;

(8)

:261

(31 August 2026)

PDF Full Text (39) Reporting Checklist Peer Review File COI Form Open Access

Lipid metabolic reprogramming of tumor-associated macrophages drives resistance to immune checkpoint blockade in lung cancer: a narrative review of mechanisms and therapeutic strategies

Tong Wu, Yun Jiang

Translational Lung Cancer Research

2026;

(8)

:262

(31 August 2026)

PDF Full Text (37) Reporting Checklist Peer Review File COI Form Open Access

Narrative review of research progress and future development of bispecific antibodies in lung cancer: opportunities and challenges

Yunfei Dai, Jing Fei

Translational Lung Cancer Research

2026;

(8)

:263

(31 August 2026)

PDF Full Text (40) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Robotic subxiphoid-optical thymectomy for Good’s syndrome in a severely immunocompromised patient: a case report

Rintaro Kawanishi, Masanori Shimomura, Satoru Okada, Tatsuo Furuya, Atsuki Uchibori, Machiko Nishii, Taiyo Kawamura, Takumi Nakagawa, Tsunehiro Ii, Masayoshi Inoue

Translational Lung Cancer Research

2026;

(8)

:264

(31 August 2026)

PDF Full Text (39) Reporting Checklist Peer Review File COI Form Open Access

EZR-ROS1-rearranged lung adenocarcinoma presenting as diffuse cystic lung disease mimicking lymphangioleiomyomatosis: a case report

Ziyin You, Wanda Bi, Hui Cao, Yan Wang, Chenjun Shi, Ying Zhou, Li Li

Translational Lung Cancer Research

2026;

(8)

:265

(31 August 2026)

PDF Full Text (40) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

Enozertinib in EGFR Exon 20ins mutants: a game changer for CNS metastases, or a temporary conquest?

Naoki Furuya

Translational Lung Cancer Research

2026;

(8)

:266

(31 August 2026)

PDF Full Text (51) Peer Review File COI Form Open Access

Letter to the Editor

Clarifying the nutritional and functional context of gut microbiome signals during chemotherapy for advanced non-small cell lung cancer

Jiahui Xiong, Chenghua Lu

Translational Lung Cancer Research

2026;

(8)

:267

(31 August 2026)

PDF Full Text (52) COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Full Text (339380) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Full Text (91290) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Full Text (84183) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Full Text (70585) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Full Text (61749) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Full Text (49446) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Full Text (49281) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Full Text (45918) Chinese (6928) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Full Text (44350) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Full Text (43243) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Full Text (39798) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Full Text (35633) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Full Text (34676) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Full Text (33356) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Full Text (32879) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Full Text (32644) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Full Text (31369) COI Form Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Full Text (30190) Open Access

Review Article

Global trends of lung cancer mortality and smoking prevalence

Farhad Islami, Lindsey A. Torre, Ahmedin Jemal

Published online: 20 August 2015

PDF Full Text (29932) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Full Text (29565) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Editorial Commentary

Unlocking the central nervous system sanctuary in EGFR-mutant non-small cell lung cancer: molecular insights and therapeutic signals from amivantamab-lazertinib in leptomeningeal disease

Elvire Pons-Tostivint, Manon Robert, Chloé Sauzay

Published online: 02 September 2026

Original Article

Toripalimab Combined with Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma: a Phase II Proof-of-Concept Study

Jie Dai, Xinyun Fang, Xinsheng Zhu, Xinnan Xu, Dongliang Bian, Xiaogang Liu, Wenxin He, Liang Duan, Peng Zhang, Gening Jiang

Published online: 31 August 2026

Original Article

Adjuvant Alectinib Versus Crizotinib in Completely Resected ALK-Positive Non-Small-Cell Lung Cancer: A Real-World Retrospective Cohort Study

Yitao Yang, Shenhua Liang, Ruihe Liu, Jiayuan Tian, Xingyu Luo, Guowei Ma

Published online: 31 August 2026

Case Report

Two Cases of Extremely Rare Primary Tracheal Hyalinizing Clear Cell Carcinoma: Case Report

Dixuan Zhang, Chudong Wang, Yuxuan Li, YenZhir Tay, Shuben Li

Published online: 31 August 2026

Original Article

Synergistic Effects and Molecular Mechanisms of Pirfenidone Combined with EGFR‑TKIs in Non‑small Cell Lung Cancer

Pan Tang, Chen Huang, Fengmei Zhang, Jiayi Li, Weimin Li, Chenliang Zhang, Zhoufeng Wang

Published online: 28 August 2026

Original Article

Plasma Proteomic Profiles Associated with LDCT Findings and Incident Lung Cancer: A Prospective Pilot Study

Antti Tikkanen, Sanna Iivanainen, Milla E K Luukkainen, Jussi P Koivunen

Published online: 28 August 2026

Original Article

Impact of Different TP53 Mutation Subtypes on Response and Outcome in Advanced Lung Adenocarcinoma Receiving First-line Immunotherapy or Chemo-immunotherapy

Xiru Quan, Wendi Xuzhang, Shengping Shen, Ying Yang, Yongfeng Yu, Shun Lu

Published online: 28 August 2026

Original Article

Electromagnetic navigation bronchoscopy-guided three-dimensional conformal microwave ablation for unresectable peripheral high-risk pulmonary nodules: a mid-term assessment with no real-time intraoperative CT/CBCT guidance

Yawei Liu, Yan Huang, Xiaodan Lin, Shijie Lu, Junying Chen, Jiyang Chen, Xiuying Xie, Kongjia Luo

Published online: 26 August 2026

Original Article

Activity and specificity of KRAS variants-directed Revolution Medicines compounds (RMC) for pleural effusion-derived NSCLC cell lines

Sandra Stickler, Marie-Therese Eggerstorfer, Maximilian Rieche, Lukas Weigl, Martin Hohenegger, Karl Kashofer, Maximilian J. Hochmair, Gerhard Hamilton

Published online: 21 August 2026

Study Protocol

Exploratory Study to Evaluate the Combined Effect of CBM588: Clostridium butyricum in Platinum plus Pemetrexed with Pembrolizumab for Non-Small Cell Lung Cancer——Protocol of MIYABRO study

Ryuta Tagawa, Hirokazu Taniguchi, Norihito Kaku, Kazumasa Akagi, Hiromi Tomono, Noritaka Honda, Yosuke Dotsu, Midori Matsuo, Shinnosuke Takemoto, Akisato Itagaki, Koki Yamashita, Yasuhiro Umeyama, Hiroshi Gyotoku, Takaya Ikeda, Nanae Sugasaki, Kazutoshi Yoshiyama, Takeshi Kitazaki, Katsumi Nakatomi, Daisuke Takao, Minoru Fukuda, Katsunori Yanagihara, Hiroshi Mukae

Published online: 18 August 2026

Original Article

A Structural Dose–Response Relationship Between Lymph Node Yield and Survival After Anatomical Segmentectomy for Early-Stage NSCLC: A SEER-Based Retrospective Cohort Study

Ye Tian, Edoardo Zanfrini, Etienne Abdelnour-Berchtold, Jean Yannis Perentes, Thorsten Krueger, Michel Gonzalez

Published online: 17 August 2026

Original Article

Prognostic Impact of Immune-Related Adverse Events in Non-Completers of Durvalumab Consolidation Therapy for Non-Small Cell Lung Cancer: A Single-Center Retrospective Cohort Study

Noriyuki Ebi, Ryoma Kawabata, Makoto Fujimoto, Ami Hirata, Yuuka Sakaki, Yusuke Otsuka, Eriko Kinoshita, Yuki Shundo, Toyoshi Yanagihara, Hiroyuki Inoue, Masaki Fujita

Published online: 17 August 2026

Original Article

Efficacy and Safety of Third-Generation EGFR-TKI Rechallenge Therapy in Advanced Non-Small Cell Lung Cancer Patients with EGFR mutation: A Retrospective Cohort Study

Jiajie Sun, Xinjing Li, Bingxue Wang, Zhangxuan Chen, Yang Yao, Ranpu Wu, Xiaohua Pan, Xuanhao Xu, Yunxiao Si, Hongbing Liu

Published online: 13 August 2026

Original Article

Multimodal Digital Assessment of Early Recovery After Chest Tube Omission in Early-Stage Lung Cancer Patients Undergoing Wedge Resection: A Post Hoc Analysis of a Prospective Cohort

Yang Chen, Runchen Wang, Youfang Li, Menghan He, Kaishen Chen, Xiaoqing Lan, Taimin Zhu, Hengrui Liang, Wei Wang, Jianxing He, Wenwei Guo, Zhexue Hao

Published online: 13 August 2026

Original Article

Interpretable deep learning and radiomics for predicting the occurrence of brain metastases following prophylactic brain irradiation in small cell lung cancer

Xingtong Zhang, Lei Zhao, Jie Wang, Xuerou Zhang, Xilong Liang, Wenwei Cao, Ying Huang, Yunhua Xu

Published online: 11 August 2026

Original Article

Bioelectrical impedance-derived body composition and systemic therapy outcomes in non-small cell lung cancer

Xin Zheng, Rui Gao, Boao Jiang, Yihai Wei, Jingwen Diao, Bo Cheng, Jianfu Li, Jingting Su, Yuejiao Su, Wenhai Fu, Peiling Chen, Xianzhe Fan, Wenhua Liang, Ying Deng

Published online: 11 August 2026

Original Article

A Modified Cryobiopsy Specimen Retrieval Method Using a Thin Bronchoscope and Small Guide Sheath for the Diagnosis of Peripheral Pulmonary Lesions

Yuki Takigawa, Kenichiro Kudo, Ken Sato, Mayu Goda, Keisuke Shiraha, Takeru Ichikawa, Shoichiro Matsumoto, Suzuka Matsuoka, Sho Mitsumune, Jun Nishimura, Hiromi Watanabe, Keiichi Fujiwara

Published online: 11 August 2026

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.